• Markets
    • icon
  • Companies
BGT · ASX

Bio-Gene Technology Ltd. (ASX:BGT)

AU$0.058

 0.0 (0.0%)
ASX:Live
08/12/2023 12:00:00 AM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

BGT Overview

BGT Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About BGT

Website

Bio-Gene Technology Ltd.

Telephone

N/A

Address

Description

Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. Its novel platform technology is based on occurring beta-triketones, a type of chemistry that may offer solutions for insect management control in animal health and crop protection as well as in public health applications. The company was founded on November 8, 1995 and is headquartered in Melbourne, Australia.

BGT Price Chart

Key Stats

Market Cap

AU$11.68M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.13

Trade Value (12mth)

AU$1,560.00

1 week

13.73%

1 month

-3.33%

YTD

-42%

1 year

-47.27%

All time high

0.35

Key Fundamentals

EPS 3 yr Growth

13.600%

EBITDA Margin

%

Operating Cashflow

-$3m

Free Cash Flow Return

-69.00%

ROIC

-65.20%

Interest Coverage

N/A

Quick Ratio

6.20

Other Data

Shares on Issue (Fully Dilluted)

178m

HALO Sector

Industrials

Next Company Report Date

22-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

BGT Announcements

Latest Announcements

Date Announcements

31 July 23

Gene Technology Ltd. - Appendix 4E and 2023 Annual Report

×

Gene Technology Ltd. - Appendix 4E and 2023 Annual Report

31 July 23

Gene Technology Ltd. - Appendix 4G

×

Gene Technology Ltd. - Appendix 4G

31 January 23

Gene Technology Ltd. - Appendix 4C - 31 December 2022

×

Gene Technology Ltd. - Appendix 4C - 31 December 2022

31 January 22

Gene Technology Ltd. - Appendix 4C - 31 December 2021

×

Gene Technology Ltd. - Appendix 4C - 31 December 2021

31 August 21

Gene Technology Ltd. - Bio-Gene to Present at Australian Mosquito Control Symposium

×

Gene Technology Ltd. - Bio-Gene to Present at Australian Mosquito Control Symposium

30 September 22

Gene Technology Ltd. - Notice Required Under ASX Listing Rule 3.13.1

×

Gene Technology Ltd. - Notice Required Under ASX Listing Rule 3.13.1

30 October 23

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

×

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

30 October 23

Gene Technology Ltd. - Appointment of Joint Company Secretary

×

Gene Technology Ltd. - Appointment of Joint Company Secretary

30 November 22

Gene Technology Ltd. - Bio-Gene to Present at Biocides Europe 2022

×

Gene Technology Ltd. - Bio-Gene to Present at Biocides Europe 2022

30 November 21

Gene Technology Ltd. - Bio-Gene 2021 AGM Presentation

×

Gene Technology Ltd. - Bio-Gene 2021 AGM Presentation

30 November 21

Gene Technology Ltd. - Bio-Gene 2021 AGM - CEO's Presentation

×

Gene Technology Ltd. - Bio-Gene 2021 AGM - CEO's Presentation

29 October 21

Gene Technology Ltd. - 2021 Notice of Annual General Meeting/Proxy Form

×

Gene Technology Ltd. - 2021 Notice of Annual General Meeting/Proxy Form

29 August 23

Gene Technology Ltd. - Initial Director's Interest Notice - T Grogan

×

Gene Technology Ltd. - Initial Director's Interest Notice - T Grogan

28 October 20

Gene Technology Ltd. - 2020 Notice of Annual General Meeting/Proxy Form

×

Gene Technology Ltd. - 2020 Notice of Annual General Meeting/Proxy Form

28 June 23

Gene Technology Ltd. - Allowance of USA Patent

×

Gene Technology Ltd. - Allowance of USA Patent

28 July 23

Gene Technology Ltd. - BGT Appoints New CEO

×

Gene Technology Ltd. - BGT Appoints New CEO

28 July 23

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

×

Gene Technology Ltd. - Quarterly Activities/Appendix 4C Cash Flow Report

28 July 23

Gene Technology Ltd. - Chair Appointment/Resignation

×

Gene Technology Ltd. - Chair Appointment/Resignation

28 July 22

Gene Technology Ltd. - Appendix 4C - 30 June 2022

×

Gene Technology Ltd. - Appendix 4C - 30 June 2022

27 October 22

Gene Technology Ltd. - Appendix 4C - 30 September 2022

×

Gene Technology Ltd. - Appendix 4C - 30 September 2022

27 November 23

Gene Technology Ltd. - Becoming a substantial holder

×

Gene Technology Ltd. - Becoming a substantial holder

27 November 19

Gene Technology Ltd. - Bio-Gene Presenting at Investor Conferences

×

Gene Technology Ltd. - Bio-Gene Presenting at Investor Conferences

27 July 23

Gene Technology Ltd. - Change of Director's Interest Notice - R Jagger

×

Gene Technology Ltd. - Change of Director's Interest Notice - R Jagger

27 July 23

Gene Technology Ltd. - BGT Executes Agreement with STK

×

Gene Technology Ltd. - BGT Executes Agreement with STK

27 January 22

Gene Technology Ltd. - Results of Meeting - EGM

×

Gene Technology Ltd. - Results of Meeting - EGM

27 April 23

Gene Technology Ltd. - Appendix 4C - 31 March 2023

×

Gene Technology Ltd. - Appendix 4C - 31 March 2023

BGT Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.02 -0.02 -0.02 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.02 -0.02 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -8.0 -8.6 3.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.01 -0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.9 -5.6 -26.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock -7.8 -10.0 -25.0 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.03 0.04 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.03 0.03 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.1 30.7 -49.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 137 153 168 Lock Lock Lock
Basic m Lock Lock Lock Lock 137 153 168 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -49.0 611.9 -66.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 4 3 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.4 261.5 -191.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -176.6 40.1 -109.9 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 277 60 210 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -3 -3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1.2 -15.2 -6.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,664.6 -754.7 -2,400.7 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -3 -3 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -1.1 -14.6 -6.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -4,751.2 -764.5 -2,431.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -3 -4 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.0 -21.6 -6.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,827.3 -653.8 -2,074.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -2 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 4 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -2 -2 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.2 -9.4 -63.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -29.2 -4.5 -22.0 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 4 6 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 5 7 4 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 -6 -3 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Equity $m Lock Lock Lock Lock 4 6 3 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 6 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.3 47.6 -48.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -47.9 -39.9 -80.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -56.4 -46.5 -96.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -58.0 -64.8 -76.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -46.8 -55.4 -65.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -35.6 -37.9 -69.0 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 1.9 0.8 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -92.6 -101.2 -92.8 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.9 6.9 6.2 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.9 6.9 6.2 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 84.3 90.6 83.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -308.0 -197.5 -570.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.1 0.9 0.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 140.7 49.1 79.5 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.1 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -4,642.7 -751.2 -2,373.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -58.1 -45.8 -92.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -47.9 -39.9 -80.7 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -56.4 -46.5 -96.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -56.4 -46.5 -96.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 2,934.7 393.9 1,080.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 2,934.7 393.9 1,080.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 291.8 209.8 196.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 2,642.9 184.0 884.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

BGT Shortsell

Frequently Asked Questions

The current share price of Bio-Gene Technology Ltd. (BGT:ASX) is AU$0.058.
The 52-week high share price for Bio-Gene Technology Ltd. (BGT:ASX) is AU$0.13.
The 52-week low share price for Bio-Gene Technology Ltd. (BGT:ASX)? is AU$0.05.
Bio-Gene Technology Ltd. (BGT:ASX) does not pay a dividend.
Bio-Gene Technology Ltd. (BGT:ASX) does not pay a dividend.
Bio-Gene Technology Ltd. (BGT:ASX) does not offer franking credits.
Bio-Gene Technology Ltd. (BGT:ASX) is classified in the Industrials.
The current P/E ratio for Bio-Gene Technology Ltd. (BGT:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.